| Revenue | DKK 42K | +148% |
| EBITDA | DKK 4K | +114% |
| Net profit | DKK -4K | +83% |
| Total assets | DKK 893K | -19% |
| Equity | DKK 716K | +0% |
| Employees | 1 | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -23 | 164 | 306 | 180 | 309 | 245 | 407 | 17 | 42 |
| Staff expenses | -0 | -54 | -43 | -45 | -37 | -51 | -85 | -43 | -39 |
| EBITDA | -23 | 109 | 263 | 135 | 272 | 194 | 322 | -26 | 4 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -23 | 109 | 263 | 135 | 272 | 194 | 322 | -26 | 4 |
| Net financials | -0 | -0 | -2 | -2 | -5 | -6 | -5 | -1 | -7 |
| Profit before tax | -23 | 110 | 260 | 133 | 268 | 188 | 317 | -27 | -3 |
| Tax | -4 | 23 | 57 | 30 | 59 | 42 | 71 | -5 | 1 |
| Net profit | -19 | 87 | 203 | 103 | 208 | 146 | 246 | -21 | -4 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 108 | 356 | 500 | 746 | 938 | 1.044 | 1.153 | 1.101 | 893 |
| Equity | 47 | 134 | 337 | 440 | 648 | 794 | 741 | 719 | 716 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 61 | 223 | 163 | 306 | 290 | 250 | 412 | 382 | 177 |
| Total debt | 61 | 223 | 163 | 306 | 290 | 250 | 412 | 382 | 177 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BA Founder | Founder | 2016 | — | — |
AA Management | Management | 2016 | — | — |
KD Founder | Founder | 2016 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2016 |
| Person | Role here | Other companies |
|---|---|---|
| BioFedora AB | Founder | 0 companies |
| Alexander August Rein | Management | 0 companies |
| Knud Dencker-Jensen | Founder | 0 companies |